Neoplasms by Site Completed Phase 3 Trials for Pemetrexed (DB00642)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03134872A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCTreatment